News
-
-
COMMUNIQUÉ DE PRESSE
Moderna Receives Health Canada Approval for RSV Vaccine for Adults Aged 60 Years and Older
Health Canada approves Moderna's mRESVIA, a single-dose mRNA vaccine against RSV for adults aged 60 and older in a convenient pre-filled syringe. The vaccine's approval follows successful Phase 3 trial ConquerRSV -
-
-
COMMUNIQUÉ DE PRESSE
NioCorp Provides Preliminary Financial Results for the Three Months Ended September 30, 2024
NioCorp provides preliminary financial results for the three-month period ended September 30, 2024, reporting a loss of $2.1 million compared to $3.2 million in 2023. Company cautions about reliance on the preliminary figures -
-
-
COMMUNIQUÉ RÉGLEMENTÉ
Louis Hachette Group annonce la publication de son Document d’Information en vue de sa cotation sur Euronext Growth (Paris)
Louis Hachette Group annonce la publication de son Document d'Information en vue de sa cotation sur Euronext Growth (Paris). La scission partielle de Vivendi SE implique l'admission des actions ordinaires le 16 décembre 2024 -
-